Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced or Metastatic ER+ Breast Cancer × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Ovarian Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hyperglycemia 1 Exanthema 1 Advanced or Metastatic ER+ Breast Cancer 1 Advanced Breast Cancer 1

Interventions

ribociclib 1 LSZ102 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02734615 2022-08-01

Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

Novartis

Phase 1 Terminated

Advanced or Metastatic ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡